Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review

  • ID: 1291952
  • SWOT Analysis
  • 38 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Green Cross Corp
  • Huons Co Ltd
  • Yuhan Corp
  • Yungjin Pharm Co Ltd
  • MORE
Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, capsules, ointments, injections, liquids and sprays. It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others. The company also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. It operates across Asia including Indonesia, China, Vietnam, Thailand and India; and the US. Daewoong Pharma is headquartered in Seoul, South Korea.

Daewoong Pharmaceutical Co Ltd Key Recent Developments

Sep 28,2016: Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension
May 26,2016: Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
May 26,2016: Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection
Apr 30,2016: Daewoong Pharmaceuticals signs 29 billion won export contract with Jordan and Iraq
Apr 06,2016: Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Green Cross Corp
  • Huons Co Ltd
  • Yuhan Corp
  • Yungjin Pharm Co Ltd
  • MORE
Section 1 - About the Company
  • Daewoong Pharmaceutical Co Ltd - Key Facts
  • Daewoong Pharmaceutical Co Ltd - Key Employees
  • Daewoong Pharmaceutical Co Ltd - Major Products and Services
  • Daewoong Pharmaceutical Co Ltd - History
  • Daewoong Pharmaceutical Co Ltd - Company Statement
  • Daewoong Pharmaceutical Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Daewoong Pharmaceutical Co Ltd - Business Description
  • Daewoong Pharmaceutical Co Ltd - Corporate Strategy
  • Daewoong Pharmaceutical Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Daewoong Pharmaceutical Co Ltd - Strengths
  • Daewoong Pharmaceutical Co Ltd - Weaknesses
  • Daewoong Pharmaceutical Co Ltd - Opportunities
  • Daewoong Pharmaceutical Co Ltd - Threats
  • Daewoong Pharmaceutical Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Daewoong Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 28, 2016: Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension
  • May 26, 2016: Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection
  • Apr 30, 2016: Daewoong Pharmaceuticals signs 29 billion won export contract with Jordan and Iraq
  • Apr 06, 2016: Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Daewoong Pharmaceutical Co Ltd, Key Facts
  • Daewoong Pharmaceutical Co Ltd, Key Employees
  • Daewoong Pharmaceutical Co Ltd, Major Products and Services
  • Daewoong Pharmaceutical Co Ltd, History
  • Daewoong Pharmaceutical Co Ltd, Other Locations
  • Daewoong Pharmaceutical Co Ltd, Subsidiaries
  • Daewoong Pharmaceutical Co Ltd, Key Competitors
  • Daewoong Pharmaceutical Co Ltd, Ratios based on current share price
  • Daewoong Pharmaceutical Co Ltd, Annual Ratios
  • Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
  • Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
  • Daewoong Pharmaceutical Co Ltd, Interim Ratios
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Daewoong Pharmaceutical Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Daewoong Pharmaceutical Co Ltd, Performance Chart (2012 - 2016)
  • Daewoong Pharmaceutical Co Ltd, Ratio Charts
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Yungjin Pharm Co Ltd
  • Yuhan Corp
  • Sam Chun Dang Pharm Co Ltd
  • Huons Co Ltd
  • Green Cross Corp
  • Dong-A Socio Holdings Co Ltd
  • DAE HWA Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll